Adherence, satisfaction, and experience with metformin 500 mg prolonged release formulation in Indian patients with type 2 diabetes mellitus: a postmarketing observational study

Adherence, satisfaction, and experience with metformin 500 mg prolonged release formulation in Indian patients with type 2 diabetes mellitus: a postmarketing observational study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.2147/IJGM.S179622
P932PMC publication ID6460999
P698PubMed publication ID31040711

P2093author name stringK M Prasanna Kumar
Sanjeev Phatak
Ami Sanghvi
Chaitanya Kotla
Manoj Chawla
Nadiminty G Sastry
Sanjay Choudhari
P2860cites workStandards of Medical Care in Diabetes-2017: Summary of RevisionsQ88988726
Understanding and overcoming metformin gastrointestinal intolerance.Q30240030
Effects of metformin extended release compared to immediate release formula on glycemic control and glycemic variability in patients with type 2 diabetesQ33713860
Assessment of efficacy and tolerability of once-daily extended release metformin in patients with type 2 diabetes mellitusQ33763380
Curse of the ghost pills: the role of oral controlled-release formulations in the passage of empty intact shells in faeces. Two case reports and a literature review relevant to psychiatryQ33949355
Patient-centred pharmaceutical design to improve acceptability of medicines: similarities and differences in paediatric and geriatric populationsQ34410837
Diagnosis and treatment of swallowing disorders (dysphagia) in acute-care stroke patientsQ34582959
Oesophageal transit of six commonly used tablets and capsulesQ34766250
Association of Organic Cation Transporter 1 With Intolerance to Metformin in Type 2 Diabetes: A GoDARTS Study.Q35675566
Blood Glucose Control and Medication Adherence Among Adult Type 2 Diabetic Nigerians Attending A Primary Care Clinic in Under-resourced Environment of Eastern NigeriaQ36132343
Safety, tolerability, and efficacy of metformin extended-release oral antidiabetic therapy in patients with type 2 diabetes: an observational trial in AsiaQ36546955
Compliance to anti-diabetic drugs: observations from the diabetic clinic of a medical college in kolkata, IndiaQ36816657
Factors affecting therapeutic compliance: A review from the patient's perspectiveQ36822915
Difficult to swallow: patient preferences for alternative valproate pharmaceutical formulationsQ37423776
The current state of diabetes mellitus in IndiaQ37575753
Advantages of extended-release metformin in patients with type 2 diabetes mellitusQ37835611
Patients' evaluation of shape, size and colour of solid dosage formsQ47198281
The effect of size and shape of tablets on their esophageal transitQ47212455
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2017 EXECUTIVE SUMMARY.Q47773960
P275copyright licenseCreative Commons Attribution-NonCommercial 3.0 UnportedQ18810331
P6216copyright statuscopyrightedQ50423863
P407language of work or nameEnglishQ1860
P921main subjectmetforminQ19484
type 2 diabetesQ3025883
NoncomplianceQ4047355
P304page(s)147-159
P577publication date2019-01-01
P1433published inInternational Journal of General MedicineQ6051402
P1476titleAdherence, satisfaction, and experience with metformin 500 mg prolonged release formulation in Indian patients with type 2 diabetes mellitus: a postmarketing observational study
P478volume12

Reverse relations

Q89538082Role of AYUSH Therapies in Modern Medicine: A Qualitative Study to Explore the Awareness and Attitudes of Doctors Towards the Utilization of Alternate System of Medicine for Diabetes Mellituscites workP2860

Search more.